STAT3 and cancer: Albeit transient STAT3 activation under controlled conditions may be beneficial, many risks are involved in its constitutive activation as evidenced by myriad of diseases resulting in degeneration, fibrosis, and cancer development of various organs (Catlett‐Falcone et al., 1999).